
Absci Corp (ABSI) is a biotech company that produces protein development technologies. As a data-first generative artificial intelligence (AI) drug creator, ABSI uses an integrated drug development platform that builds on traditional biological drug discovery with the help of AI to optimize multiple characteristics of the drug that may prove to be important towards development and effect of the drug.
Founded in 2011, the company operates out of Vancouver, Washington. Valued at a market cap of $408 million, the small-cap biotech is a component of the benchmark Russell 2000 Index (RUT).